premise: TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug.
hypothesis: The HIV drug is being approved for use in the usa
reason: We don't know if its being approved it's just been applied for "being approved" implies they are allowing its use. The system thinks being approved is the same as applying 